Productos farmacéuticos y dispositivos médicos

Featured news

AIM successfully launches its Calculator for Fair Medicines Prices in Europe

The International Association of Mutual Benefit Societies (AIM) has launched today its calculator for fair medicines prices in Europe (German version here). The calculator transposes AIM's fair pricin......

11.06.2021 - Read more

AIM calls for a Pharmaceutical Strategy shaped to ensure and promote solidarity and sustainable healthcare in the European Union

AIM, the International Association of Mutual Benefit Societies, has articulated a set of recommendations to rebalance pharmaceutical markets in Europe. AIM calls for the European Pharmaceutical Str......

03.07.2020 - Read more

Other news

Mejoras en la asequibilidad y la sostenibilidad mediante nuevos modelos de fijación de precios, rentabilidad y reembolso para evaluar las tecnologías sanitarias innovadoras (siglas en inglés: ASCERTAIN)

AIM participa en un proyecto europeo sobre la asequibilidad de los med...

28.11.2022- Read more

Declaración conjunta sobre la revisión de la legislación farmacéutica de las asociaciones que representan a los proveedores de servicios sanitarios, los pacientes, los profesionales de la salud y los pagadores

Mejorar el acceso de los pacientes a medicamentos de alta calidad y as...

09.11.2022- Read more

“Better treatment for better health: lifting the veil on treatment optimisation” – Stakeholders exchange views on patient-centred clinical research at EORTC and AIM’s seminar

Treatment optimisation is defined as clinical research in real-world c...

24.06.2022- Read more

La Comisión Europea abre su consulta pública sobre la revisión de la legislación farmacéutica básica

El 28 de septiembre la Comisión Europea abrió su consulta pública s...

01.10.2021- Read more

Payer involvement is important for a successful EU HTA framework!

The International Association of Mutual Benefit Societies (AIM) welcom...

08.07.2021- Read more

AIM successfully launches its Calculator for Fair Medicines Prices in Europe

The International Association of Mutual Benefit Societies (AIM) has la...

11.06.2021- Read more

Joint Statement – Transparency is needed to reap the full benefits of the EU’s investment in its Vaccines Strategy

Ahead of Friday 18 September's webinar the EU Vaccine Strategy, a numb...

21.09.2020- Read more

AIM calls for a Pharmaceutical Strategy shaped to ensure and promote solidarity and sustainable healthcare in the European Union

AIM, the International Association of Mutual Benefit Societies, has ar...

03.07.2020- Read more

EU Collaboration on Vaccination

The current outbreak of COVID-19, its crippling effects on European ec...

22.04.2020- Read more
1 2